Evidence map

TrialDiabetes, obesity & metabolism2013

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin.

C Kapitza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

71 papers cite itlatest 60 shown

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 23368510